With the recent feature by The Business Times spotlighting the 2025 Emerging Enterprise Awards — themed “Redefining industries through innovation and insight” The Business Times+1 — we at ALPS Group Inc. reaffirm our commitment to being more than a biotech company. We are a catalyst for change.
From our Malaysian headquarters, ALPS is building platforms that combine advanced science, scalable manufacturing, and strategic insight to reshape sectors: regenerative medicine, cell & gene therapy, precision diagnostics, and mRNA-driven solutions. The Awards’ emphasis on how emerging enterprises drive real-world impact mirrors our own vision: innovation must translate into improved lives, broader access and systemic change.
As ALPS moves into its next phase — global expansion, deeper collaborations, and even stronger R&D pipelines — we remain focused on one principle: innovation governed by insight. Insight into unmet patient needs, insight into scalable ecosystems, insight into how to make world-class therapies available beyond narrow geographies.
🔗 Read the original article here: The Business Times
